CSUN Drug and Alcohol Abuse Prevention Program (DAAPP)

ABOUT THE DRUG-FREE SCHOOLS AND COMMUNITIES ACT AND PREPARATION OF THE DAAPP

The Drug-Free Schools and Communities Act (DFSCA) and its Part 86 implementing regulations impose ongoing, annual and biennial requirements for the California State University (CSU) to comply as a condition of receiving federal funds. The purpose of the DFSCA is to prevent the unlawful possession, use and distribution of illicit drugs and alcohol by students and employees on institutional property, or as part of any of its activities.

The CSU is committed to providing a safe and welcoming environment conducive to learning, teaching and working for students and employees. Part of that commitment means understanding and taking seriously our obligations to inform the university community of available resources as well as the disciplinary, health, and legal consequences of use and misuse of alcohol and illegal drugs. Accordingly, the university DFSCA/Part 86 Compliance Official is designated with the responsibility for establishing and maintaining procedures consistent with facilitating institutional compliance with the following requirements:

  • Maintaining a comprehensive Drug and Alcohol Abuse Prevention Program (DAAPP) document on behalf of the university that contains all required components.
  • Annually distributing the DAAPP document to all students (excluding those enrolled in continuing education courses) and employees, and actively distributing to students and employees that join the university after the initial annual distribution.
  • Completing a biennial review process of the DAAPP in order to determine its effectiveness and ensure that disciplinary sanctions imposed by the university are consistently enforced.

STANDARDS OF CONDUCT

All CSU students, faculty, staff, and visitors are subject to CSU policies, as well as local, state, and federal laws regarding the unlawful possession, manufacturing, distribution, sale, or use of alcohol and illegal drugs.

The unlawful manufacturing, distribution, possession, sale or use of illicit drugs and alcohol on university property or as any part of its activities is prohibited. Individuals in violation may be subject to arrest or citation. The University Police Department (UPD) enforces laws pertaining to alcohol and drugs at most CSU owned, controlled and officially recognized locations. External law enforcement agencies also enforce laws pertaining to alcohol and drugs at activities and locations that may or may not be owned, controlled and officially recognized by the university. Students, faculty and staff in violation of alcohol and drug laws may also be referred to the Offices of Student Conduct or University Personnel for administrative discipline.

The Chancellor’s Office of the California State University System maintains various policies that establish oversight, guidelines and procedures for operations of the universities. These include the following related to alcohol and drugs:

  • California State University Policy on Systemwide Smoke and Tobacco Free Environment governs the implementation of smoke and tobacco free environments at all CSU institutions. All California State University campuses are required to be 100% Smoke Free and Tobacco Free. Smoking, the use or sale of tobacco products, and the use of designated smoking areas are prohibited on all California State University properties. Members of the CSU community are expected to fully comply with the policy. Any sponsorship and/or advertising in respect to any university activity or event by a tobacco product manufacturer is prohibited unless explicitly authorized by the University President or designee.
  • California State University has a Sales, Service, and Advertising of Alcoholic Beverages policy that governs all CSU institutions regarding the sale and service of alcoholic beverages at or in conjunction with University intercollegiate athletic events, and advertising of alcoholic beverages on campus and at University athletic facilities.
  • The CSU Student Conduct Process Policy is established pursuant to Cal. Code Regs. Tit. 5, § 41301 et seq., and governs all Student disciplinary matters systemwide, except that as noted in Article IV of the Policy and in the CSU Nondiscrimination Policy. Pursuant to this and other applicable university policies, the institution will impose sanctions (consistent with local, state and federal law) upon students based on the following grounds from Cal. Code Regs. Tit. 5, § 41301.
    • Use, possession, manufacture, or distribution of illegal drugs or drug-related paraphernalia, (except as expressly permitted by law and University regulations) or the misuse of legal pharmaceutical drugs.
    • Use, possession, manufacture, or distribution of alcoholic beverages (except as expressly permitted by law and University regulations), or public intoxication while on campus or at a University related activity.

University Level Standards of Conduct

The California State University (CSU) judicial process is governed by the CSU Student Conduct Process. At California State University, Northridge (CSUN), the Student Conduct Administrator is the Assistant Dean of Students and Director of Student Conduct and Ethical Development (ADOS), under the purview of the University’s chief judicial officer, Vice President of Student Affairs/Dean of Students. Reports of violations of the Student Conduct Code or the campus policy on the Use of Alcohol and Illicit Drugs, are referred to the ADOS for review of the facts and circumstances contained in written referrals.

Below are definitions of the formal disciplinary sanctions as defined by CSU Student Conduct Process (Article V):

  1. Disciplinary Probation. A designated period of time during which privileges of continuing in Student status are conditioned upon future behavior. Conditions may include the potential loss of specified privileges to which a current Student would otherwise be entitled, or the probability of more severe disciplinary sanctions if the Student is found to violate the Student Conduct Code or any University policy during the probationary period.
  2. Suspension. Temporary separation of the Student from Student status from the California State University system.
    1. A Student who is suspended for less than one year shall be placed on inactive Student (or equivalent) status (subject to individual Campus policies) and remains eligible to re-enroll at the University or another campus (subject to individual Campus enrollment policies) once the suspension has been served. Conditions for re-enrollment may be specified.
    2. A Student who is suspended for one year or more shall be separated from Student status but remains eligible to reapply to the University or another campus (subject to individual Campus application polices) once the suspension has been served. Conditions for readmission may be specified.
    3. Suspension of one year or more, withdrawals in lieu of suspension, and withdrawals with pending misconduct investigations or disciplinary proceedings shall be entered on the Student's transcript permanently without exception; this requirement shall not be waived in connection with a resolution agreement.
  3. Expulsion. Permanent separation of the Student from Student status from the California State University system. Expulsion, withdrawal in lieu of expulsion, and withdrawal with pending misconduct investigation or disciplinary proceeding shall be entered on the Student's transcript permanently, without exception; this requirement shall not be waived in connection with a resolution agreement.

Additional information on university policies can be found in:

  1. CSU Student Conduct Process
  2. Standards for Student Conduct
  3. CSUN Use of Alcohol and Illicit Drugs Policy (under revision)
  4. CSUN Drug Free Workplace Policy and Procedural Guidelines
  5. New Student Orientation New Student Handbook
  6. Matador Involvement Center - Code of Ethics for University Recognized Student Clubs and Organizations
  7. Residential Life - Student Housing Rules and Regulations

APPLICABLE LEGAL PENALTIES, ADMINISTRATIVE DISCIPLINE AND SANCTIONS

Controlled substances are classified into one of five numerical designation schedules in accordance with standards and procedures under the federal Controlled Substances Act. The following provides a brief overview of the schedules of controlled substances. Note that as a Title IV participating institution, the University does not permit recreational marijuana because marijuana is classified as an illegal substance under federal law. For more information please review the Systemwide Law Enforcement Policy on Medical Marijuana.

Schedule I

  • The drug or other substance has a high potential for abuse.
  • The drug or other substance has no currently accepted medical use in treatment in the United States.
  • There is a lack of accepted safety for use of the drug or other substance under medical supervision.

Schedule II

  • The drug or other substance has a high potential for abuse.
  • The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
  • Abuse of the drug or other substance may lead to severe psychological or physical dependence.

Schedule III

  • The drug or other substance has less potential for abuse than the drugs or other substances in Schedules I and II.
  • The drug or other substance has a currently accepted medical use in treatment in the United States.
  • Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.

Schedule IV

  • The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule III.
  • The drug or other substance has a currently accepted medical use in treatment in the United States.
  • Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule III.

Schedule V

  • The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule IV.
  • The drug or other substance has a currently accepted medical use in treatment in the United States.
  • Abuse of the drug or other substances may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule IV.

Federal Penalties for Possession and Other Controlled Substance Related Violations (excluding trafficking)

The following tables are not representative of all possible penalties in all circumstances.

OffensePenalties (Fine / Imprisonment)
Simple PossessionFirst Offense: At least $1000 / 1 year maximum

Second Offense: At least $2500 / Between 15 days and 2 years

Third Offense: At least $5000 / Between 90 days and 3 years
Use of Controlled Substance to Commit Crime of Violence$250,000 / 20 years maximum
Endangering Human Life While Illegally Manufacturing a Controlled Substance$250,000 / 10 years maximum
Attempt and ConspiracySame as penalties prescribed for the underlying offense
Robberies and Burglaries Involving Controlled SubstancesRobberies Involving Controlled Substances: Up to $250,000 / Up to any number of years or life

Burglaries Involving Controlled Substances: Up to $250,000 / Up to any number of years or life

Conspiracy to Commit Robbery or Burglary Involving Controlled Substances: Up to $250,000 / Up to 10 years

Federal Trafficking Penalties

Federal trafficking penalties are derived from the 2020 Edition of the 2024 Edition of the Drug Enforcement Administration Drugs of Abuse Resource Guide.

SubstanceQuantityFederal PenaltiesQuantityFederal Penalties
Cocaine (Schedule II)500 - 4999 grams mixtureFirst Trafficking Offense: Not less than 5 yrs, and not more than 40 yrs. If death or serious injury, not less than 20 yrs or more than life. Fine of not more than $5 million if an individual, $25 million if not an individual.

Second Trafficking Offense: Not less than 10 yrs and not more than life. If death or serious bodily injury, life imprisonment. Fine of not more than $8 million if an individual, $50 million if not an individual.
5 kilograms or more mixtureFirst Trafficking Offense: Not less than 10 yrs and not more than life. If death or serious injury, not less than 20 yrs or more than life. Fine of not more than $10 million if an individual, $50 million if not an individual.

Second Trafficking Offense: Not less than 15 yrs, and not more than life. If death or serious injury, life imprisonment. Fine of not more than $20 million if an individual, $75 million if not an individual.

2 or More Prior Felony Trafficking Offenses: Not less than 25 years. Fine of not more than $20 million if an individual, $75 million if not an individual.
Cocaine Base (Schedule II)28 - 279 grams mixtureSame as above280 grams or more mixtureSame as above
Fentanyl (Schedule II)40 - 399 grams mixtureSame as above400 grams or more mixtureSame as above
Fentanyl Analogue (Schedule I)10 - 99 grams mixtureSame as above100 grams or more mixtureSame as above
Heroin (Schedule I)100 - 999 grams mixtureSame as above1 kilogram or more mixtureSame as above
LSD (Schedule I)1 - 9 grams mixtureSame as above10 grams or more mixtureSame as above
Methamphetamine (Schedule II)5 - 49 grams pure or 50 - 499 grams mixtureSame as above50 grams or more pure or 500 grams or more mixtureSame as above
PCP (Schedule II)10 - 99 grams pure or 100 - 999 grams mixtureSame as above100 grams or more pure or 1 kilogram or more mixtureSame as above
SubstanceQuantityFederal Trafficking Penalties
All Schedule V DrugsAny AmountFirst Offense: Not more than 1 yr. Fine not more than $100,000 if an individual, $250,000 if not an individual. Second Offense: Not more than 4 yrs. Fine not more than $200,000 if an individual, $500,000 if not an individual.
All Other Schedule IV DrugsAny AmountFirst Offense: Not more than 5 yrs. Fine not more than $250,000 if an individual, $1 million if not an individual.

Second Offense: Not more than 10 yrs. Fine not more than $500,000 if an individual, $2 million if other than an individual.
Flunitrazepam (Schedule IV)<1 gramSee above
Flunitrazepam (Schedule IV)1 gramFirst Offense: Not more than 20 yrs. If death or serious injury, not less than 20 yrs, or more than life. Fine $1 million if an individual, $5 million if not an individual.

Second Offense: Not more than 30 yrs. If death or serious bodily injury, life imprisonment. Fine $2 million if an individual, $10 million if not an individual.
Other Schedule I & II DrugsAny AmountSee above
Any Drug Product Containing Gamma Hydroxybutyric AcidAny AmountSee above
Other Schedule III DrugsAny AmountFirst Offense: Not more than 10 years. If death or serious injury, not more than 15 yrs. Fine not more than $500,000 if an individual, $2.5 million if not an individual.

Second Offense: Not more than 20 yrs. If death or serious injury, not more than 30 yrs. Fine not more than $1 million if an individual, $5 million if not an individual.
Marijuana (Schedule I)1,000 kg or more marijuana mixture; or 1,000 or more marijuana plantsFirst Offense Penalty: Not less than 10 yrs. or more than life. If death or serious bodily injury, not less than 20 yrs., or more than life. Fine not more than life. Fine not more than $10 million if an individual, $50 million if other than an individual.

Second Offense Penalty: Not less than 15 yrs. or more than life. If death or serious bodily injury, life imprisonment. Fine not more than $20 million if an individual, $75 million if other than an individual.
Marijuana (Schedule I)100 kg to 999 kg marijuana mixture; or 100 to 999 marijuana plantsFirst Offense Penalty: Not less than 5 yrs. or more than 40 yrs. If death or serious bodily injury, not less than 20 yrs., or more than life. Fine not more than life. Fine not more than $5 million if an individual, $25 million if other than an individual.

Second Offense Penalty: Not less than 10 yrs. or more than life. If death or serious bodily injury, life imprisonment. Fine not more than $8 million if an individual, $50 million if other than an individual.
Marijuana (Schedule I)More than 10 kg hashish; 50 to 99 kg marijuana mixture

More than 1 kg of hashish oil; 50 to 99 marijuana plants
First Offense Penalty: Not less than 20 yrs. If death or serious bodily injury, not less than 20 yrs., or more than life. Fine $1 million if an individual, $5 million if other than an individual.

Second Offense Penalty: Not less than 30 yrs. If death or serious bodily injury, life imprisonment. Fine $2 million if an individual, $10 million if other than an individual.
Marijuana (Schedule I)Less than 50 kilograms marijuana (except 50 or more marijuana plants regardless of weight)

1 to 49 marijuana plants;
First Offense Penalty: Not more than 5 yrs. Fine not more than $250,000, $1 million if other than an individual.

Second Offense Penalty: Not more than 10 yrs. Fine $500,000 if an individual, $2 million if other than individual
Hashish (Schedule I)10 kg or lessSee above
Hashish Oil (Schedule I)1 kg or lessSee above

As demonstrated in the chart above, the minimum sentence for a violation after two or more prior convictions for a felony drug offense have become final is a mandatory term of life imprisonment without release and a fine up to $20 million if an individual and $75 million if other than an individual.

State Penalties

The State of California maintains more than 200 laws regarding unlawful possession, manufacturing, distribution, sale and use of drugs and alcohol for individuals and businesses. These laws are organized into code types that include but are not limited to the following:

  • Business and Professions Code
  • Harbors and Navigation Code
  • Health and Safety Code
  • Penal Code
  • Public Utilities Code
  • Vehicle Code
  • Welfare and Institutions Code

You are encouraged to review the following California laws regarding use, sale, and distribution of alcohol and other drugs by individuals or businesses. The full text of these state laws and their associated penalties can be found in the code search section of the California Legislative Information website.

California Business and Professions Code (BPC)

DIVISION 9 Alcoholic Beverages 23000-25762

California Civil Code

DIVISION 3 Obligations, Part 3, 1714 a-d

Furnishing alcohol to an intoxicated person or minor.

California Health and Safety Code

DIVISION 10 Uniform Controlled Substances Act

Vehicle Code

DIVISION 11 Rules of the Road 21000-23336

Driving under the influence; use and possession.

DIVISION 11.5. Sentencing for Driving While Under the Influence 23500-23675

The full text of these state laws and their associated penalties can be found in the code search section of the following California Legislative Information website.

California Department of Alcoholic Beverage Control

The sale and service of alcoholic beverages must be conducted in accordance with all local and state laws, including but not limited to the California Alcoholic Beverage Control Act and any regulations under the auspices of the California Department of Alcoholic Beverage Control. Additional information about penalties that may be imposed on entities in violation of state drug and alcohol laws can be found at the following website: https://www.abc.ca.gov/law-and-policy/penalty-guidelines/

Local Ordinances

Cities and counties in California can establish ordinances and pose penalties pertaining to possession, manufacturing, distribution, sale and use of drugs and alcohol. Proposed legal sanctions for local alcohol and other drug violations are decided by the court and filing district or city attorney. Sanctions may include fines, community service, incarceration, and more. A searchable municipal code library is provided by American Legal Publishing include:

  • Section 41.27. Intoxication
  • Sections 47.50. Narcotics, Violent Crime, Unlawful Weapon or Ammunition Crime, and Gang Related Crime Eviction Program

Administrative Discipline and Sanctions Involving Students

Students and student organizations alleged to have violated university policy or local, state or federal law pertaining to alcohol and drugs are subject to university administrative discipline procedures and/or referral to the appropriate authorities for legal action. Administrative disciplinary proceedings for students are independent from court or other legal proceedings. Accordingly, administrative discipline may still be instituted against a student that is also charged in civil or criminal courts for alleged violation of laws. The university may proceed before, simultaneously with, or after any judicial or other administrative proceedings, except in cases involving Discrimination, Harassment, Retaliation, Sexual Misconduct, Dating or Domestic Violence, or Stalking. In such cases, the university shall proceed without delay pursuant to Article IV in the CSU Systemwide Student Conduct Procedures.

Consistent with the CSU Systemwide Student Conduct Procedures, the university will impose sanctions (consistent with local, state and federal law) upon students and student organizations found to violate the standards of conduct outlined above and in applicable university policies. Sanctions can be imposed on applicants, enrolled students, students between academic terms, graduates awaiting degrees, and students who withdraw from school while a disciplinary matter is pending.

Potential sanctions may include, but are not limited to those described below:

  1. Restitution. Compensation for loss, damages or injury. This may include appropriate service and/or monetary material replacement.
  2. Loss of Privilege. Removal from participation in recognized student clubs and organizations (e.g. fraternities and sororities), and/or University events.
  3. Educational and Remedial Sanctions. Assignments, such as work, research, essays, service to the University or the community, training, counseling, or other remedies intended to discourage similar misconduct or as deemed appropriate based upon the nature of the violation.
  4. Denial of Access to Campus or Persons. A designated period of time during which the Student is not permitted: (i) on University Property or specified areas of Campus, or (ii) to have contact (physical or otherwise) with the Complainant, witnesses or other specified persons.
  5. Disciplinary Probation. A designated period of time during which privileges of continuing in Student status are conditioned upon future behavior. Conditions may include the potential loss of specified privileges to which a current Student would otherwise be entitled, or the probability of more severe disciplinary sanctions if the Student is found to violate the Student Conduct Code or any University policy during the probationary period.
  6. Suspension. Temporary separation of the Student from active Student status or Student status.
    1. Student who is suspended for less than one year shall be placed on inactive Student (or equivalent) status (subject to individual Campus policies) and remains eligible to re-enroll at the University (subject to individual Campus enrollment policies) once the suspension has been served. Conditions for re-enrollment may be specified.
    2. Student who is suspended for one year or more shall be separated from Student status but remains eligible to reapply to the University (subject to individual Campus application polices) once the suspension has been served. Conditions for readmission may be specified.
    3. Suspension of one year or more, withdrawals in lieu of suspension, and withdrawals with pending misconduct investigations or disciplinary proceedings shall be entered on the Student's transcript permanently without exception; this requirement shall not be waived in connection with a resolution agreement.
  7. Expulsion. Permanent separation of the Student from Student status from the California State University system. Expulsion, withdrawal in lieu of expulsion, and withdrawal with pending misconduct investigation or disciplinary proceeding shall be entered on the Student's transcript permanently, without exception; this requirement shall not be waived in connection with a resolution agreement.
  8. Administrative Hold and Withholding a Degree. The University may place an administrative hold on registration transactions and release of records and transcripts of a Student who has been sent written notice of a pending investigation or disciplinary case concerning that Student, and may withhold awarding a degree otherwise earned until the completion of the process set forth herein, including the completion of all sanctions imposed.
  9. Record of Discipline. A record of disciplinary probation or suspension is entered on a Student's transcript, with beginning and end date, for the duration of the sanction. A record of expulsion or suspension for one year or more or a withdrawal in lieu of suspension or expulsion shall note the effective date of discipline and remains on the transcript permanently, without exception. A withdrawal with pending misconduct investigation or disciplinary proceeding remains on the transcript until a final outcome is rendered in the matter. These requirements shall not be waived in connection with any resolution agreement.

Administrative Discipline and Sanctions Involving Recognized Student Organization

Per CSU's Student Activities Policy, each University must have a conduct process for recognized student organizations. Examples of sanctions that Universities might utilize for organizations include:


 

  1. Event Restriction(s): Limitations placed on student organizations ability to host events.
  2. Restitution of Damages: Compensation for loss, damages or injury. This may include appropriate service and/or monetary material replacement.
  3. Report of Violation(s) to Organization Headquarters: Consultation and/or referral of violations to applicable local, national or international organization headquarters.
  4. Required Alcohol and/or Other Drugs Education Program: Online or in-person training module or counseling provided by university offices such as Student Conduct and Ethical Development or Student Counseling and Psychological Services.
  5. Loss of University Recognition: Removal from participation in recognized student clubs and organizations (e.g., fraternities and sororities), and/or University events. Depending on the circumstances, such removal may also include temporary or permanent loss of access to on-campus space, funds, other university resources or ability to be a recognized as a university organization.

Note that more than one sanction may be imposed for a single violation.

Administrative Discipline and Sanctions Involving Employees

Employees alleged to have violated university policy or local, state or federal law pertaining to alcohol and drugs are subject to university administrative discipline procedures and/or referral to the appropriate authorities for legal action. Administrative disciplinary proceedings for university personnel are independent from court or other legal proceedings. Additionally, the University Police may be consulted on referral of cases for criminal prosecution. Accordingly, administrative discipline may still be instituted against an employee that is also charged in civil or criminal courts for alleged violation of laws. Pursuant to California Education Code Section 89535, CSU Collective Bargaining Agreements and CSU Systemwide policies where applicable, the university will impose sanctions (consistent with local, state and federal law) upon employees found to violate the standards of conduct outlined above and in applicable university policies. Potential sanctions imposed by the university may include, but are not limited to those described below. One or more sanctions may be imposed upon review and analysis of the severity of the infraction(s).

  1. Participation in Treatment Program: May be utilized, for example, as part of a disciplinary action as described above, in a last chance agreement, or in any other appropriate action as determined by the University.
  2. Reprimand: A disciplinary document detailing the infraction, expectations moving forward, and inclusion of the document in the official personnel file.
  3. Demotion: A demotion is a reduction in rank or job title with associated reduction in salary and/or benefits.
  4. Suspension: A temporary separation, without pay and/or benefits, of the employee from the university. The length of the separation would be determined by the severity of infraction and/or prior infractions.
  5. Termination: Permanent separation of the employee from the university with complete cessation of pay and benefits.

HEALTH RISKS ASSOCIATED WITH USE AND ABUSE OF ALCOHOL AND OTHER DRUGS

The table below provides an overview of the health risks associated with use and abuse of alcohol and other drugs. The university also offers online awareness programs through the CSULearn Learning management system to provide students with awareness of issues related to drug use and misuse, skills to manage their behaviors around substances, and the health and behavioral impacts of substances.

SubstanceRisk of Substance Abuse and/or Dependence Based on Controlled Substance SchedulePotential Short-Term and/or Long Term Effects on the Mind and/or BodyEffects of Overdose
AlcoholNot scheduledReduced inhibitions, slurred speech, motor impairment, confusion, memory problems, concentration problems, coma, breathing problems, alcohol use disorder, additional health problems and increased risk for certain cancersAlcohol overdose can lead to permanent brain damage or death
AmphetaminesMany amphetamines are Schedule II stimulants, which means that they have a high potential for abuse and a currently acceptable medical use (in FDA-approved products).Increased blood pressure and pulse rates, insomnia, loss of appetite, and physical exhaustionAgitation, increased body temperature, hallucinations, convulsions, and possible death
BarbituratesBarbiturates are Schedule II, III, and IV depressants, which range between having low and high levels of potential for abuse. Levels of physical or psychological dependence range from limited to severeBarbiturates slow the central nervous system and cause mild euphoria, lack of restraint, relief of anxiety, and sleepiness. Higher doses cause impairment of memory, judgment, and coordination; irritability; and paranoid and suicidal ideation.Central nervous system depression, decreased respiration, increased heart rate, decreased blood pressure, decreased urine production, decreased body temperature, coma, and possible death
Bath SaltsA number of synthetic substances are classified under Schedule I, which have high potential for abuse.Euphoria, alertness, psychological effects such as confusion, acute psychosis, agitation, combativeness, aggressive, violent, and self-destructive behavior; as well as paranoia, hallucinations, and delusions. Adverse or toxic effects include rapid heartbeat; hypertension; hyperthermia; prolonged dilation of the pupil of the eye; breakdown of muscle fibers that leads to release of muscle fiber contents into bloodstream; teeth grinding; sweating; headaches; palpitations; seizures.Reports of death from individuals abusing drugs in this class indicate the seriousness of the risk users are taking when ingesting these products.
BenzodiazepinesBenzodiazepines are controlled in Schedule IV which have low potential for abuse and may lead to limited physical or psychological dependence.Benzodiazepines are associated with amnesia, hostility, irritability, and vivid or disturbing dreams. Benzodiazepines slow down the central nervous system and may cause sleepiness and relaxed mood.Extreme drowsiness, confusion, impaired coordination, decreased reflexes, respiratory depression, coma, and possible death. Overdose effects of concomitant use of benzodiazepines and opioids include: Profound sedation, respiratory depression, coma, and death.
CocaineCocaine is a Schedule II drug under the Controlled Substances Act, meaning it has a high potential for abuse and has an accepted medical use for treatment in the United States. Abuse may lead to severe psychological or physical dependence.A rapid-onset, intense euphoric effect known as a “rush”, increased alertness and excitation, as well as restlessness, irritability, and anxiety. Taking high doses of cocaine or prolonged use, such as binging, usually causes paranoia. The crash that follows euphoria is characterized by mental and physical exhaustion, sleep, and depression lasting several days. Following the crash, users experience a craving to use cocaine again.Irregular heartbeat, ischemic heart conditions, sudden cardiac arrest, convulsions, strokes, and death.
Cychorphine

Source: LACDPH News Release October 15, 2026
Cychlorphine is an opioid drug, like fentanyl and heroin, that is more potent than fentanyl and can cause respiratory depression and death.Opioids reduce pain and can cause a high, but they can also slow breathing — and result in death. The risk of death increases when opioids, such as cychlorphine, are used with other drugs, such as alcohol, sedatives, painkillers, illicit street drugs, or prescription drugs. Cychlorphine is particularly dangerous due to its strength, where a very small amount can cause someone to stop breathing.Overdose can slow breathing and result in death.
DXM (Dextromethorphan)DXM is a legally marketed cough suppressant that is neither a controlled substance nor a regulated chemical under the Controlled Substances Act.Confusion, inappropriate laughter, agitation, paranoia, euphoria, and hallucinations. Other sensory changes, including the feeling of floating and changes in hearing and touch. Overexcitability, lethargy, loss of coordination, slurred speech, sweating, hypertension, nausea, vomiting, and involuntary spasmodic movement of the eyeballs.DXM overdose can be treated in an emergency room setting and generally does not result in severe medical consequences or death. Most DXM related deaths are caused by ingesting the drug in combination with other drugs. DXM-related deaths also occur from impairment of the senses, which can lead to accidents.
Ecstasy or MDMA (also known as Molly)MDMA is a Schedule I drug under the Controlled Substances Act, meaning it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.Confusion, anxiety, depression, paranoia, sleep problems, and drug craving. Muscle tension, tremors, involuntary teeth clenching, muscle cramps, nausea, faintness, chills, sweating, and blurred vision.MDMA can interfere with the body’s ability to regulate temperature. On occasions, this can lead to a sharp increase in body temperature (hyperthermia), resulting in liver, kidney, and cardiovascular system failure, and death. Because MDMA can interfere with its own metabolism (that is, its breakdown within the body), potentially harmful levels can be reached by repeated drug use within short intervals
FentanylFentanyl is a Schedule II narcotic under the United States Controlled Substances Act of 1970, which means there is high potential for abuse which may lead to severe psychological or physical dependence. Illicitly produced fentanyl is sold alone or in combination with heroin and other substances and has been identified in fake pills, mimicking Pharmaceutical drugs such as oxycodoneFentanyl, similar to other commonly used opioid analgesics (e.g., morphine), produces effects such as relaxation, euphoria, pain relief, sedation, confusion, drowsiness, dizziness, nausea, vomiting, urinary retention, pupillary constriction, and respiratory depression.Overdose may result in stupor, changes in pupillary size, cold and clammy skin, cyanosis, coma, and respiratory failure leading to death. The presence of triad of symptoms such as coma, pinpoint pupils, and respiratory depression are strongly suggestive of opioid poisoning
GHB - GammaHydroxybutyric AcidGHB is a Schedule I controlled substance, meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. FDA-approved GHB products are Schedule III substances under the Controlled Substances Act. In addition, GBL is a List I chemical. GHB was placed on Schedule I of the Controlled Substances Act in March 2000. However, when sold as FDAapproved GHB products (such as Xyrem®), it is considered Schedule III, one of several drugs that are listed in multiple schedules.Euphoria, drowsiness, decreased anxiety, confusion, and memory impairment. Unconsciousness, seizures, slowed heart rate, greatly slowed breathing, lower body temperature, vomiting, nausea, coma, and death.GHB overdose can cause coma and death.
HeroinHeroin is a Schedule I substance under the Controlled Substances Act meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.Because it enters the brain so rapidly, heroin is particularly addictive, both psychologically and physically. Heroin users report feeling a surge of euphoria or “rush” followed by a twilight state of sleep and wakefulness. Drowsiness, respiratory depression, constricted pupils, nausea, a warm flushing of the skin, dry mouth, and heavy extremities.Slow and shallow breathing, blue lips and fingernails, clammy skin, convulsions, coma, and possible death.
HydromorphoneHydromorphone is a Schedule II drug under the Controlled Substances Act with an accepted medical use as a pain reliever. Hydromorphone has a high potential for abuse and use may lead to severe psychological or physical dependence.When used as a drug of abuse, and not under a doctor’s supervision, hydromorphone is taken to produce feelings of euphoria, relaxation, sedation, and reduced anxiety. It may also cause mental clouding, changes in mood, nervousness, and restlessness. It works centrally (in the brain) to reduce pain and suppress cough. Hydromorphone use is associated with both physiological and psychological dependence. Constipation, pupillary constriction, urinary retention, nausea, vomiting, respiratory depression, dizziness, impaired coordination, loss of appetite, rash, slow or rapid heartbeat, and changes in blood pressure.Acute overdose of hydromorphone can produce: Severe respiratory depression, drowsiness progressing to stupor or coma, lack of skeletal muscle tone, cold and clammy skin, constricted pupils, and reduction in blood pressure and heart rate Severe overdose may result in death due to respiratory depression.
InhalantsThe common household products that are misused as inhalants are legally available for their intended and legitimate uses. Many state legislatures have attempted to deter youth who buy legal products to get high by placing restriction on the sale of these products to minors. Even though some substances are not currently controlled by the Controlled Substances Act, they pose risks to individuals who abuse them.Inhalant abuse can cause damage to the parts of the brain that control thinking, moving, vision, and hearing. Cognitive abnormalities can range from mild impairment to severe dementia. Weight loss, muscle weakness, disorientation, inattentiveness, lack of coordination, irritability, depression, and damage to the nervous system and other organs.Because intoxication lasts only a few minutes, users try to prolong the high by continuing to inhale repeatedly over the course of several hours, which is a very dangerous practice. With successive inhalations, users may suffer loss of consciousness and/or death.
KetamineKetamine is a chemical compound approved by the FDA for use in short-term sedation and anesthesia in humans and animals. A ketamine derivative, esketamine, is approved by the FDA for treatment-resistant depression in adults.Effects of Ketamine may include altered perception, happiness, feelings of detachment from environment, out-of-body sensations, headache, dizziness, sleepiness, feeling strange or “loopy”, difficulty speaking, numbness, blurred vision, nausea. Long-term, heavy use of ketamine is associated with memory problems, depression, anxiety, abdominal pain, and ketamine-induced uropathy, a condition that causes symptoms like those of a urinary tract infection. At higher doses, a person may experience extreme detachment from their body and reality.An overdose can cause unconsciousness and dangerously slowed breathing.
KhatThe chemicals found in khat are controlled under the Controlled Substances Act. Cathine is a Schedule IV stimulant, and cathinone is a Schedule I stimulant under the Controlled Substances Act, meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.Khat can induce manic behavior with: grandiose delusions, paranoia, nightmares, hallucinations, and hyperactivity; Chronic khat use can result in violence and suicidal depression. Khat causes an immediate increase in blood pressure and heart rate. Khat can also cause a brown staining of the teeth, insomnia, and gastric disorders. Chronic use of khat can cause physical exhaustion. Additionally, there are reports of liver damage (Chemical hepatitis) and of cardiac complications, specifically myocardial infarctions.The dose needed to constitute an overdose is not known, however it has been historically associated with those who are long-term chewers of the leaves. Symptoms of toxicity include: Delusions, loss of appetite, difficulty with breathing, and increases in both blood pressure and heart rate.
KratomKratom is not controlled under the Controlled Substances Act; however, there may be some state regulations or prohibitions against the possession and use of kratom. The FDA has not approved Kratom for any medical use. In addition, DEA has listed kratom as a Drug and Chemical of Concern.At low doses, kratom produces stimulant effects with people reporting increased alertness, physical energy, and talkativeness. At high doses, people experience sedative effects. Kratom consumption can lead to addiction. Several cases of psychosis resulting from use of kratom have been reported, where individuals addicted to kratom exhibited psychotic symptoms, including hallucinations, delusion, and confusion Kratom’s effects on the body include nausea, itching, sweating, dry mouth, constipation, increased urination, tachycardia, vomiting, drowsiness, and loss of appetite. Users of kratom have also experienced anorexia, weight loss, insomnia, hepatotoxicity, seizure, and hallucinations.The dose needed to constitute an overdose is not known.
LSDLSD is a Schedule I substance under the Controlled Substances Act. Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.Physical effects include: dilated pupils, higher body temperature, increased heart rate and blood pressure, sweating, loss of appetite, sleeplessness, dry mouth, and tremors. During the first hour after ingestion, users may experience visual changes with extreme changes in mood. While under the influence, the person may suffer impaired depth and time perception accompanied by distorted perception of the shape and size of objects, movements, colors, sound, touch, and the user’s own body image. The ability to make sound judgments and see common dangers is impaired, making the user susceptible to personal injury. It is possible for users to suffer acute anxiety and depression after an LSD “trip.” Hallucinogen Persisting Perception Disorder, which may include fragmentary recurrences of certain aspects of the drug experience or “flashbacks” have been reported days, and even months, after taking the last dose.Longer, more intense “trip” episodes may occur with larger doses. Serious psychological harm can occur after administration, including fear, paranoia, depression, and anxiety, and can be long-lasting. Death after LSD use is rare.
MarijuanaMarijuana is scheduled under the Controlled Substances Act. Unauthorized possession or use remains illegal under federal law.Problems with memory and learning, distorted perception, difficulty in thinking and problem-solving, and loss of coordination. The effect of marijuana on perception and coordination are responsible for serious impairments in learning, associative processes, and psychomotor behavior (driving abilities). Short-term physical effects from marijuana use may include: Sedation, bloodshot eyes, increased heart rate, coughing from lung irritation, increased appetite, and increased blood pressure (although prolonged use may cause a decrease in blood pressure). Long term, regular use can lead to physical dependence and withdrawal following discontinuation, as well as psychological addiction or dependence. Marijuana smokers experience serious health problems such as bronchitis, emphysema, and bronchial asthma. Extended use may cause suppression of the immune system. Withdrawal from chronic use of high doses of marijuana causes physical signs including headache, shakiness, sweating, and stomach pains and nausea. Withdrawal symptoms also include behavioral signs such as Restlessness, irritability, sleep difficulties, and decreased appetiteNo deaths from overdose of marijuana have been reported. Although, there have been an increasing number of emergency room visits involving marijuana edibles.
MethadoneMethadone is a Schedule II drug under the Controlled Substances Act. While it may legally be used under a doctor’s supervision, its non-medical use is illegal. Methadone has high potential for abuse which may lead to severe psychological or physical dependence.Abuse of methadone can lead to psychological dependence. Sweating, itchy skin, or sleepiness. Individuals who abuse methadone risk becoming tolerant of and physically dependent on the drug. When use is stopped, individuals may experience withdrawal symptoms including: Anxiety, muscle tremors, nausea, diarrhea, vomiting, and abdominal cramps.The effects of a methadone overdose are slow and shallow breathing, blue fingernails and lips, stomach spasms, clammy skin, convulsions, weak pulse, coma, and possible death.
MethamphetamineMethamphetamine is a Schedule II stimulant under the Controlled Substances Act, which means that it has a high potential for abuse and a currently accepted medical use (in FDA-approved products). It is available only through a prescription that cannot be refilled.Intense sensation, or rush. Oral ingestion or snorting produces a long lasting high instead of a rush, which reportedly can continue for as long as half a day. Long-term meth use results in many damaging effects, including addiction. Chronic meth users can exhibit violent behavior, anxiety, confusion, insomnia, and psychotic features including paranoia, aggression, visual and auditory hallucinations, mood disturbances, and delusions — such as the sensation of insects creeping on or under the skin. Such paranoia can result in homicidal or suicidal thoughts.High doses may result in death from stroke, heart attack, or multiple organ problems caused by overheating.
MorphineMorphine is a Schedule II narcotic under the Controlled Substances Act, which has high potential for abuse which may lead to severe psychological or physical dependenceMorphine’s effects include euphoria and relief of pain. Chronic use of morphine results in tolerance, and physical and psychological dependence. Morphine use results in relief from physical pain, decrease in hunger, and inhibition of the cough reflex.Cold and clammy skin, lowered blood pressure, sleepiness, slowed breathing, slow pulse rate, coma, and possible death.
OpiumOpium is a Schedule II drug under the Controlled Substances Act. Most opioids are Schedule II, III, IV, or V drugs. Some drugs that are derived from opium, such as heroin, are Schedule I drugs. Drugs in all schedules range in levels of abuse potential resulting in various levels of psychological or physical abuse.The intensity of opium’s euphoric effects on the brain depends on the dose and route of administration. It works quickly when smoked because the opiate chemicals pass into the lungs, where they are quickly absorbed and then sent to the brain. An opium “high” is very similar to a heroin “high”; users experience a euphoric rush, followed by relaxation and the relief of physical pain. Opium inhibits muscle movement in the bowels leading to constipation. It also can dry out the mouth and mucous membranes in the nose. Opium use leads to physical and psychological dependence, and can lead to overdose.Overdose effects include: Slow breathing, seizures, dizziness, weakness, loss of consciousness, coma, and possible death.
OxycodoneOxycodone products are in Schedule II of the Controlled Substances Act, which has high potential for abuse which may lead to severe psychological or physical dependence.Euphoria and feelings of relaxation are the most common effects of oxycodone on the brain, which explains its high potential for abuse. Physiological effects of oxycodone include: Pain relief, sedation, respiratory depression, constipation, papillary constriction, and cough suppression. Extended or chronic use of oxycodone containing acetaminophen may cause severe liver damageOverdose effects include: Extreme drowsiness, muscle weakness, confusion, cold and clammy skin, pinpoint pupils, shallow breathing, slow heart rate, fainting, coma, and possible death.
Peyote and MescalinePeyote and mescaline are Schedule I substances under the Controlled Substances Act, meaning that they have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.Use of peyote and mescaline will cause varying degrees of: Illusions, hallucinations, altered perception of space and time, and altered body image. People may also experience euphoria, which is sometimes followed by feelings of anxiety. Following the consumption of peyote and mescaline, people may experienceintense nausea, vomiting, dilation of the pupils, increased heart rate, increased blood pressure, a rise in body temperature that causes heavy perspiration, headaches, muscle weakness, and impaired motor coordinationThe dose needed to constitute an overdose is not known.
PsilocybinPsilocybin is a Schedule I substance under the Controlled Substances Act, meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.The physical effects include: Nausea, vomiting, muscle weakness, and lack of coordination. The psychological consequences of psilocybin use include hallucinations and an inability to discern fantasy from reality. Panic reactions and a psychotic-like episode also may occur, particularly if a user ingests a high dose.Effects of overdose include: Longer, more intense "trip" episodes, psychosis, and possible death. Additionally, accidental poisoning can occur when a poisonous mushroom is mistaken for a psilocybin mushroom.
RohypnolRohypnol® is a Schedule IV substance under the Controlled Substances Act. Rohypnol® is not approved for manufacture, sale, use, or importation to the United States. However, it is legally manufactured and marketed in other countries. Penalties for possession, trafficking, and distribution involving one gram or more are the same as those of a Schedule I drug.Drowsiness (sedation), sleep (pharmacological hypnosis), decreased anxiety, and amnesia (no memory of events while under the influence of the substance). Increased or decreased reaction time, impaired mental functioning and judgment, confusion, aggression, and excitability. Slurred speech, loss of motor coordination, weakness, headache, and respiratory depression. Rohypnol® also can produce physical dependence when taken regularly over a period of time.High doses of Rohypnol®, particularly when combined with CNS depressant drugs such as alcohol and heroin, can cause severe sedation, unconsciousness, slow heart rate, and suppression of respiration that may be sufficient to result in death.
Salvia DivinorumNeither Salvia divinorum nor its active constituent Salvinorin A has an approved medical use in the United States. Salvia divinorum is not controlled under the Controlled Substances Act. Salvia divinorum is, however, controlled by a number of states. Since Salvia divinorum is not controlled by the CSA, some online botanical companies and drug promotional sites have advertised Salvia as a legal alternative to other plant hallucinogens like mescaline.Psychic effects include perceptions of bright lights, vivid colors, shapes, and body movement, as well as body or object distortions. Salvia divinorum may also cause fear and panic, uncontrollable laughter, a sense of overlapping realities, paranoia, and hallucinations. Users typically experience rapid onset of intense hallucinations that can impair judgment and disrupt sensory and cognitive functions. Adverse physical effects may include: Loss of coordination, dizziness, and slurred speechThe dose needed to constitute an overdose is not known.
Spice/ K2, (Synthetic Marijuana)These substances have no accepted medical use in the United States and have been reported to produce adverse health effects. Currently, 49 substances are specifically listed as Schedule I substances under the Controlled Substances Act either through legislation or regulatory action. In addition there are many other synthetic cannabinoids that meet the definition for “cannabimimetic agent” under the Controlled Substances Act and thus are Schedule I substances.Acute psychotic episodes, dependence, and withdrawal are associated with use of these synthetic cannabinoids. Some individuals have suffered from intense hallucinations. Other effects include severe agitation, disorganized thoughts, paranoid delusions, and violence after smoking products laced with these substances. Adverse effects included tachycardia (elevated heart rate), elevated blood pressure, unconsciousness, tremors, seizures, vomiting, hallucinations, agitation, anxiety, pallor, numbness, and tingling.Severe adverse effects have been attributed to the use of synthetic cannabinoids, including nausea, vomiting, agitation, anxiety, seizures, stroke, coma, and death by heart attack or organ failure. Acute kidney injury requiring hospitalization and dialysis in several patients reportedly having smoked synthetic cannabinoids has also been reported by the Centers for Disease Control and Prevention.
SteroidsAnabolic steroids are Schedule III substances under the Controlled Substances Act. Only a small number of anabolic steroids are approved for either human or veterinary use. Anabolic steroids may be appropriately and lawfully prescribed by a licensed physician for important medical treatment, including the treatment of testosterone deficiency, delayed puberty, low red blood cell count, breast cancer, and tissue wasting resulting from viruses or diseases.Case studies and scientific research indicate that high doses of anabolic steroids may cause mood and behavioral effects. In some individuals, anabolic steroid use can cause dramatic mood swings, increased feelings of hostility, impaired judgment, and increased levels of aggression (often referred to as “roid rage”). When users stop taking steroids, they may experience depression that may be severe enough to lead one to commit suicide. Anabolic steroid use may also cause psychological dependence and addiction. A wide range of adverse effects is associated with the use or abuse of anabolic steroids. These effects depend on several factors including: Age, sex, the anabolic steroid used, amount used, and duration of use.Anabolic steroids are not associated with overdoses. The adverse effects a user would experience develop from the use of steroids over time.
Vaping and Marijuana ConcentratesMarijuana is scheduled under the Controlled Substances Act. Unauthorized possession or use remains illegal under federal law.Being a highly concentrated form of marijuana, the effects upon the user may be more psychologically and physically intense than plant marijuana use. To date, long term effects of marijuana concentrate use are not yet fully known; but, the effects of marijuana use are known. These effects include: paranoia, anxiety, panic attacks, and hallucinations. Additionally, the use of plant marijuana increases one’s heart rate and blood pressure, although prolonged use can produce hypotension. Plant marijuana users may also experience withdrawal and addiction problems.The dose needed to constitute an overdose is not known.

Sources:
https://nida.nih.gov/research-topics/commonly-used-drugs-charts
https://www.getsmartaboutdrugs.gov/publication/drug-fact-sheets
https://www.dea.gov/documents/2024/2024-12/2024-12-12/drugs-abuse-2024?utm
https://www.niaaa.nih.gov/alcohols-effects-health

AVAILABLE TREATMENT AND SUPPORT PROGRAMS

Campus

University Counseling Services (UCS) (818) 677-2366

University Counseling Services (UCS) staff provide supportive counseling sessions to students who feel challenged by substance use including referrals to treatment beyond the scope of UCS’ services, and support to those students reentering campus following treatment. Any CSUN student experiencing concern about their substance use can schedule an initial evaluation appointment with Dr. Steve Silver.

UCS Alcohol and Other Drugs Counseling
Dr. Steve Silver, Psychologist and Alcohol and Other Drugs Counselor, UCS (818) 677-2366

LifeMatters®

LifeMatters® by Empathia, CSU's confidential Employee Assistance Program (EAP), is dedicated to employee well-being. From emotional and family counseling to providing geriatric care management, LifeMatters® offers both online and in-person support. Employees can visit LifeMatters® online for more information, using university-assigned password available from their benefits office. Employees who want to speak to someone from LifeMatters® confidentially can call 800-367-7474.

Klotz Student Health Center (818) 677-3666

Division of Student Affairs Office (818) 677-2391

Community Support

Al-Anon (888) 425-2666

Alcoholics Anonymous (818) 988-3001

Cocaine Anonymous (818) 760-8402

Marijuana Anonymous (800) 766-6779

Narcotics Anonymous (818) 773-9999

Community Treatment Programs

Local treatment centers include:

Los Angeles County Department of Health Services, Substance Abuse Prevention & Control (844) 804-7500

Cri-Help (fee for service) (818) 985-8323

Tarzana Treatment Centers (fee for service)

National Treatment Locator

FindTreatment.gov is the Substance Abuse and Mental Health Services Administration’s (SAMHSA) confidential and anonymous resource for persons seeking treatment for mental and substance use disorders in the United States and its territories. FindTreatment.gov is now available in Spanish.

CAMPUS PREVENTION AND EDUCATION

CSUN is dedicated to promoting a healthy campus environment through comprehensive alcohol and drug prevention education. Klotz Student Health Center Health Promotion (Klotz Health Promotion), University Counseling Services, Women’s Research and Resource Center, and Department of Police Services offer a variety of educational programs to students and collaborate with other campus departments. These programs are designed to prevent and reduce alcohol and other drug misuse.

Klotz Health Promotion engages students in various outreach activities, including educational workshops and tabling events that raise awareness about the risks associated with substance misuse. Presentations include topics such as safer partying, alcohol alternatives, CSUN alcohol and substance use data, alcohol poisoning prevention, and naloxone use education. Social media posts focusing on alcohol and substance use prevention and education are provided throughout the academic year.

Klotz Student Health Center - Free Naloxone and Fentanyl Test Strips for Students
The Klotz Student Health Center offers free naloxone an opioid overdose reversal medication, to CSUN students in recognition of the 2022 California Senate Bill 367 and fentanyl test strips to CSUN students per California Assembly Bill 461.

Klotz Student Health Center - Prevent Drink Spiking
In accordance with California Assembly Bill 1524, the Klotz Student Health Center offers free drink spiking test strips to CSUN students.

Klotz Student Health Center - Matadors4Wellness Peer Health Education Program (818) 677-6665
Klotz Peer Educators provide alcohol, tobacco, and other drugs presentations to classes and clubs and organizations, as well as participate in campus outreach events.

Klotz Student Health Center Safe Spring Break Resource Fair
The Safe Spring Break Fair is designed to equip students with essential tools and knowledge for a safe and responsible spring break. The fair focuses on alcohol safety, recognizing and preventing alcohol poisoning, understanding standard drink measurements, and overdose prevention, including naloxone education.

CSUN Alcohol, Tobacco, and Other Drugs Advisory Committee
The CSUN Alcohol, Tobacco, and Other Drugs Advisory Committee, comprised of staff, faculty, and student leaders from various campus departments, meets twice each semester during the spring and fall semesters to discuss and provide recommendations and guidance concerning university policies, services, education, prevention, and intervention and recovery programs, that seek to address the harmful effects of alcohol, tobacco, and other drugs (ATOD) use and misuse.

National College Health Assessment (NCHA)
The NCHA is a survey developed by the American College Health Association (ACHA) to collect data on a wide range of health and wellness topics of college students, including alcohol and other drug data on behaviors and experiences. CSUN first administered the NCHA in Spring 2006 to collect data about CSUN students for internal strategic planning as well as to benchmark against national statistics, and continues to administer the NCHA approximately every two years.

(Rev. 10/29/26)